Literature DB >> 19867175

THE EXPERIMENTAL DISEASE THAT FOLLOWS THE INJECTION OF HUMAN LEPROSY BACILLI INTO FOOT-PADS OF MICE.

C C Shepard1.   

Abstract

When leprosy bacilli from human patients are inoculated into the foot-pads of CFW mice, a microscopic granuloma containing acid-fast bacilli develops in a characteristic manner. This has been seen in 22 of 22 instances with leprosy bacilli from nasal washings, in 12 of 16 instances with leprosy bacilli from skin biopsies, and in none of 16 cases where the nasal washings were not observed to contain leprosy bacilli. Quantitative studies revealed a relationship between the number of bacilli inoculated and the time required for the appearance of the lesions. The incubation period was usually 1 to 2 months when the dose was 10(5.5) to 10(6.0) bacilli and about 6 months when the dose was about 10(3) organisms. After the development of the lesion, the number of bacilli harvested was usually in the range 10(4.5) to 10(6.0), regardless of the number inoculated. When the inoculum has contained 10(2.0) to 10(3.5) acid-fast bacilli, and harvests were reasonably prompt, there were regular increases of 50- to 1000-fold. Passage to new groups of mice has been successful 11 of 12 times. Most of these were second passages. One strain has been maintained in 3 passages with a total increase in acid-fast bacilli of 4 x 10(4)-fold. Another strain has been through 4 passages with a total increase of about 4 x 10(6)-fold. Cultures on bacteriological media favorable for the growth of most known mycobacterial species have not shown growth of mycobacteria.

Entities:  

Year:  1960        PMID: 19867175      PMCID: PMC2137235          DOI: 10.1084/jem.112.3.445

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  Nonacid-fast bacteria and HeLa cells: their uptake and subsequent intracellular growth.

Authors:  C C SHEPARD
Journal:  J Bacteriol       Date:  1959-06       Impact factor: 3.490

2.  Histiocytic granulomatous mycobacterial lesions produced in the golden hamster (Cricetus auratus) inoculated with human leprosy: negative results in experiments using other animals.

Authors:  C H BINFORD
Journal:  Lab Invest       Date:  1959 Sep-Oct       Impact factor: 5.662

3.  Acid-fast bacilli in nasal excretions in leprosy, and results of inoculation of mice.

Authors:  C C SHEPARD
Journal:  Am J Hyg       Date:  1960-03

4.  Intratesticular multiplication of Mycobacterium leprae murium in normal and suramin-treated animals.

Authors:  G R HILSON; S D ELEK
Journal:  Int J Lepr       Date:  1957 Oct-Dec
  4 in total
  53 in total

1.  Hairless mice, human leprosy and thymus-derived-lymphocytes.

Authors:  K Prabhakaran; E B Harris; W F Kirchheimer
Journal:  Experientia       Date:  1975-07-15

Review 2.  Socioeconomics of a global leprosy eradication programme.

Authors:  S S Naik; R Ganapati
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

Review 3.  Leprosy as a genetic disease.

Authors:  Andrea Alter; Audrey Grant; Laurent Abel; Alexandre Alcaïs; Erwin Schurr
Journal:  Mamm Genome       Date:  2010-10-09       Impact factor: 2.957

Review 4.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

5.  Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.

Authors:  Malcolm S Duthie; Rhea N Coler; John D Laurance; Lucas H Sampaio; Regiane M Oliveira; Ana Lucia M Sousa; Mariane M A Stefani; Yumi Maeda; Masanori Matsuoka; Masahiko Makino; Steven G Reed
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

Review 6.  Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients.

Authors:  C Cocito; J Delville
Journal:  Eur J Epidemiol       Date:  1985-09       Impact factor: 8.082

7.  Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.

Authors:  Herve Dega; Abdelhalim Bentoucha; Jerome Robert; Vincent Jarlier; Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

8.  Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice.

Authors:  A Bentoucha; J Robert; H Dega; N Lounis; V Jarlier; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  IMMUNOLOGICAL IDENTIFICATION OF FOOT-PAD ISOLATES AS MYCOBACTERIUM LEPRAE BY LEPROMIN REACTIVITY IN LEPROSY PATIENTS.

Authors:  C C SHEPARD; R S GUINTO
Journal:  J Exp Med       Date:  1963-08-01       Impact factor: 14.307

Review 10.  New prospects for the study of leprosy in the laboratory.

Authors:  R J Rees
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.